关注
Hashem Khanbabaei
Hashem Khanbabaei
Kerman University of Medical Sciences
在 ajums.ac.ir 的电子邮件经过验证
标题
引用次数
引用次数
年份
Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells
F Ghasemi, M Shafiee, Z Banikazemi, MH Pourhanifeh, H Khanbabaei, ...
Pathology-Research and Practice 215 (10), 152556, 2019
2392019
Curcumin delivery mediated by bio-based nanoparticles: a review
M Moballegh Nasery, B Abadi, D Poormoghadam, A Zarrabi, P Keyhanvar, ...
Molecules 25 (3), 689, 2020
2052020
Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics
M Ashrafizadeh, Z Ahmadi, N Mohamadi, A Zarrabi, S Abasi, ...
International journal of biological macromolecules 145, 282-300, 2020
1032020
Autophagy modulators: mechanistic aspects and drug delivery systems
S Tavakol, M Ashrafizadeh, S Deng, M Azarian, A Abdoli, M Motavaf, ...
Biomolecules 9 (10), 530, 2019
762019
Circular RNA and diabetes: epigenetic regulator with diagnostic role
K Abbaszadeh-Goudarzi, S Radbakhsh, MH Pourhanifeh, H Khanbabaei, ...
Current molecular medicine 20 (7), 516-526, 2020
582020
Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance
R Shafabakhsh, F Arianfar, M Vosough, HR Mirzaei, M Mahjoubin-Tehran, ...
Cancer Gene Therapy 28 (12), 1229-1255, 2021
432021
Bismuth‐based nanomaterials: Recent advances in tumor targeting and synergistic cancer therapy techniques
S Badrigilan, J Choupani, H Khanbabaei, M Hoseini‐Ghahfarokhi, ...
Advanced Healthcare Materials 9 (7), 1901695, 2020
422020
New epigenetic players in stroke pathogenesis: from non-coding RNAs to exosomal non-coding RNAs
M Mahjoubin-Tehran, S Rezaei, A Jesmani, N Birang, K Morshedi, ...
Biomedicine & Pharmacotherapy 140, 111753, 2021
362021
Curcumin: a dietary phytochemical for targeting the phenotype and function of dendritic cells
K Rahimi, K Hassanzadeh, H Khanbabaei, SM Haftcheshmeh, A Ahmadi, ...
Current medicinal chemistry 28 (8), 1549-1564, 2021
342021
Vitamin D receptor ApaI (rs7975232), BsmI (rs1544410), Fok1 (rs2228570), and TaqI (rs731236) gene polymorphisms and susceptibility to pulmonary tuberculosis in an Iranian …
A Mohammadi, H Khanbabaei, R Nasiri-Kalmarzi, F Khademi, M Jafari, ...
Journal of Microbiology, Immunology and Infection 53 (6), 827-835, 2020
342020
An update on enterovirus 71 infection and interferon type I response
M Rasti, H Khanbabaei, A Teimoori
Reviews in medical virology 29 (1), e2016, 2019
342019
The interplay between microRNAs and Twist1 transcription factor: a systematic review
H Khanbabaei, A Teimoori, M Mohammadi
Tumor Biology 37 (6), 7007-7019, 2016
342016
microRNAs: Potential glioblastoma radiosensitizer by targeting radiation-related molecular pathways
MT Bahreyni-Toossi, E Dolat, H Khanbabaei, N Zafari, H Azimian
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 816 …, 2019
282019
Vitamin D receptor genetic polymorphisms and the risk of multiple sclerosis: A systematic review and meta-analysis
A Mohammadi, A Azarnezhad, H Khanbabaei, E Izadpanah, ...
Steroids 158, 108615, 2020
272020
Fractionated radiotherapy might induce epithelial‐mesenchymal transition and radioresistance in a cellular context manner
MJ Tahmasebi‐Birgani, A Teimoori, A Ghadiri, H Mansoury‐Asl, ...
Journal of cellular biochemistry 120 (5), 8601-8610, 2019
272019
Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications
H Khanbabaei, S Ebrahimi, JL García-Rodríguez, Z Ghasemi, ...
Journal of Experimental & Clinical Cancer Research 41 (1), 278, 2022
252022
Therapeutic potential of the miRNA–ATM axis in the management of tumor radioresistance
AH Rezaeian, H Khanbabaei, GA Calin
Cancer Research 80 (2), 139-150, 2020
252020
Harnessing CRISPR/Cas 9 System for manipulation of DNA virus genome
S Ebrahimi, A Teimoori, H Khanbabaei, M Tabasi
Reviews in Medical Virology 29 (1), e2009, 2019
242019
CRISPR-Cas system: a promising diagnostic tool for Covid-19
S Ebrahimi, H Khanbabaei, S Abbasi, M Fani, S Soltani, M Zandi, ...
Avicenna journal of medical biotechnology 14 (1), 3, 2022
202022
Targeted delivery of CRISPR/Cas13 as a promising therapeutic approach to treat SARS-CoV-2
K Abbaszadeh-Goudarzi, MH Nematollahi, H Khanbabaei, HH Nave, ...
Current pharmaceutical biotechnology 22 (9), 1149-1155, 2021
192021
系统目前无法执行此操作,请稍后再试。
文章 1–20